Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
The Netherlands Journal of Medicine
|
May 16, 2014
Outcome of patients with primary central nervous system lymphoma treated outside clinical trials
A Hart, J W Baars, M J Kersten, et al.
Nutrition Journal
|
September 10, 2020
Beyond clinical food prescriptions and mobile markets: parent views on the role of a healthcare institution in increasing healthy eating in food insecure families
Emily L DeWit, Emily M Meissen-Sebelius, Robin P Shook, et al.
Cancer Immunology, Immunotherapy : CII
|
May 21, 2005
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study
J M Kerst, A Bex, H Mallo, et al.
British Journal of Cancer
|
April 15, 2015
HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
D Meulendijks, N B Tomasoa, L Dewit, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
The Netherlands Journal of Medicine
|
May 16, 2014
Outcome of patients with primary central nervous system lymphoma treated outside clinical trials
A Hart, J W Baars, M J Kersten, et al.
Nutrition Journal
|
September 10, 2020
Beyond clinical food prescriptions and mobile markets: parent views on the role of a healthcare institution in increasing healthy eating in food insecure families
Emily L DeWit, Emily M Meissen-Sebelius, Robin P Shook, et al.
Cancer Immunology, Immunotherapy : CII
|
May 21, 2005
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study
J M Kerst, A Bex, H Mallo, et al.
British Journal of Cancer
|
April 15, 2015
HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
D Meulendijks, N B Tomasoa, L Dewit, et al.
Page
of 5